SCHEMBL671344

SCHEMBL671344

FC1=CC=CC2C(C=C1)C2(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24798926 0.60 TSHR (0.36)
SCHEMBL3468794 0.57
SCHEMBL3468797 0.57
SCHEMBL23518772 0.57
SCHEMBL20327720 0.50
SCHEMBL20787050 0.50
SCHEMBL23894391 0.50
SCHEMBL20726176 0.47
SCHEMBL14730226 0.47
SCHEMBL6832961 0.41

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130143247-A1 VOLATILE ORGANIC COMPOUNDS FOR DETECTING CELL DYSPLASIA AND GENETIC ALTERATIONS ASSOCIATED WITH LUNG CANCER TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) 2013-06-06 US claimed
WO-2012023138-A2 VOLATILE ORGANIC COMPOUNDS FOR DETECTING CELL DYSPLASIA AND GENETIC ALTERATIONS ASSOCIATED WITH LUNG CANCER TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) 2012-02-23 WO claimed
US-9315848-B2 Volatile organic compounds for detecting cell dysplasia and genetic alterations associated with lung cancer TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) 2016-04-19 US disclosed
US-20130143247-A1 VOLATILE ORGANIC COMPOUNDS FOR DETECTING CELL DYSPLASIA AND GENETIC ALTERATIONS ASSOCIATED WITH LUNG CANCER TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) 2013-06-06 US disclosed
WO-2012023138-A2 VOLATILE ORGANIC COMPOUNDS FOR DETECTING CELL DYSPLASIA AND GENETIC ALTERATIONS ASSOCIATED WITH LUNG CANCER TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) 2012-02-23 WO disclosed